| Entry |
|
|---|
| Name |
Thrombomodulin alfa (INN);
Thrombomodulin alfa (genetical recombination) (JAN)
|
|---|
| Formula |
C2230H3357N633O718S50
|
|---|
| Exact mass |
52090.1667
|
|---|
| Mol weight |
52124.5759
|
|---|
| Class |
Cardiovascular agent
DG01950 Antithrombotic agent
|
|---|
| Remark |
| Therapeutic category: | 3339 |
|
|---|
| Efficacy |
Anticoagulant |
|---|
| Comment |
recombinant Thrombomodulin [KO: K03907]
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04610 | Complement and coagulation cascades |
|
|---|
| Interaction |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
33 Blood and body fluid agents
333 Anticoagulants
3339 Others
D06410 Thrombomodulin alfa (INN); Thrombomodulin alfa (genetical recombination) (JAN)
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Serine peptidases
F2
D06410 Thrombomodulin alfa (INN) <JP>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D06410
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D06410
 |
|---|
| Other DBs |
|
|---|
| LinkDB |
 |
|---|
